Institute for Sight Innovation and Translational Health
About Us
The Institute for Sight Innovation and Translational Health (INSIGHT) is a dedicated clinical and translational research institute focused on advancing evidence-based ophthalmic care through rigorous clinical investigation and multicenter collaboration.
Mission
Our mission is to accelerate the translation of scientific discovery into meaningful therapeutic advances for patients with ocular disease.
We focus on advancing precision eye care through innovative clinical and translational research and collaborative multicenter clinical trials. We aim to become a nationally recognized institute for clinical innovation, translational discovery, and high-impact multicenter research in ophthalmology.
What We Do
-
We design and conduct:
- NIH-funded clinical trials
- Phase I–IV industry-sponsored trials
- Investigator-initiated translational studies
- Medical device and surgical innovation studies
- Biologic and regenerative therapy investigations
- Rare disease clinical studies
- Comparative effectiveness and outcomes research
Our infrastructure supports high-quality data capture, regulatory compliance, and scientifically meaningful clinical endpoints.
-
INSIGHT bridges laboratory discovery with patient care by:
- Developing and validating imaging and molecular biomarkers
- Integrating mechanistic insights into trial design
- Conducting corneal nerve and immune profiling
- Advancing genotype–phenotype correlations
- Translating neuroimmune discoveries into therapeutic strategies
- We prioritize research that directly informs clinical decision-making and therapeutic development.
-
INSIGHT develops and applies AI-driven platforms to:
- Quantify imaging biomarkers
- Characterize complex disease phenotypes
- Detect subtle structural and inflammatory changes
- Predict therapeutic response
- Enhance objectivity and reproducibility across multicenter trials
- AI integration strengthens precision medicine strategies and supports scalable translational research.
-
INSIGHT emphasizes deep disease characterization through:
- High-resolution ocular imaging
- Corneal nerve analysis
- Immune and inflammatory profiling
- Biomarker-guided patient stratification
- Longitudinal clinical phenotyping
This approach enables targeted therapy development and optimized trial design.
-
INSIGHT actively participates in multicenter clinical trials and collaborative research networks.
While not serving as a formal coordinating center, the Institute contributes scientific leadership, advanced phenotyping expertise, and specialized imaging and biomarker capabilities across participating sites.
-
INSIGHT conducts:
- Patient-reported outcome studies
- Longitudinal cohort research
- Real-world therapeutic effectiveness studies
- Post-marketing safety evaluations
We prioritize clinically meaningful endpoints that improve quality of life and long-term visual outcomes.